In DDP-resistant NSCLC patients, circRNA_100565 is highly expressed, leading to elevated ADAM metallopeptidase domain 28 (ADAM28) levels through interaction with miR-337-3p. This evidence concerns the gene ADAM28 and non-small cell lung carcinoma.